title: [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].
abstract: Neuroendocrine neoplasms of the pancreas and the gastrointestinal tract are heterogeneous regarding etiology (e.g. sporadic or hereditary), histomorphology, hormone expression, hormone-related functional activity and especially the malignant potential. In neuroendocrine neoplasms the biopsy-based diagnosis plays an important role for the clinical management of patients. The diagnosis most importantly relies on the differentiation (e.g. organoid versus diffuse growth patterns) and the grading of tumors. The latter is based on the proliferation activity as determined by Ki-67 immunostaining and mitotic count and results in the current tumor classification into neuroendocrine tumors G1, neuroendocrine tumors G2 or neuroendocrine carcinomas G3. Occasionally, tumors may show mixed differentiation containing a non-neuroendocrine cancer component. The neuroendocrine markers synaptophysin and chromogranin A are recommended for the immunohistochemical confirmation of the diagnosis. Furthermore, biopsy material can be used to investigate the expression of therapy-related markers, such as somatostatin receptor-2A. Moreover, if needed, the expression of transcription factors and hormones can be determined to obtain information on the possible site of origin of metastatic neuroendocrine neoplasms or to determine the syndrome-inducing hormone in functionally active neuroendocrine neoplasms. Finally, using the stomach as an example, biopsies may also be successfully used to investigate neuroendocrine precursor lesions which may harbor prognostic significance.
authors.affiliation: Pathologisches Institut, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Deutschland, frank.bergmann@med.uni-heidelberg.de.
authors.forename: F
authors.initials: F
authors.lastname: Bergmann
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D001706:Biopsy; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D018450:Disease Progression; D005770:Gastrointestinal Neoplasms / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D041981:Gastrointestinal Tract / Q000473:pathology; D006729:Hormones, Ectopic / Q000032:analysis; D006801:Humans; D060787:Neoplasm Grading; D018358:Neuroendocrine Tumors / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D006729:Hormones, Ectopic